Study of the biological features of in vitro cultured γδ T cells
- Authors:
- Yan Zhang
- Liming Zhi
- Zan Zhang
View Affiliations
Affiliations: Shanghai Claison Bio‑technology Co., Ltd., Shanghai 201201, P.R. China
- Published online on: November 5, 2015 https://doi.org/10.3892/br.2015.538
-
Pages:
87-91
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
The aim of the present study was to investigate the biological features of in vitro cultured γδ T cells. The γδ T cells were in vitro cultured and on different culture days cell proliferation, phenotype, killing activity and the secretion of cytokines were analyzed. Cell numbers were counted by an automated cell counter, phenotype of the cells and cytokines were analyzed by flow cytometry, and killing activities of the cells against gastric cancer SGC‑7901 cells were tested using the cell counting kit‑8. From days 7 to 14, in vitro cultured γδ T cells enter the exponential phase. On day 14, maximum proliferation fold was observed, and on day 10, the maximum specific growth rate µmax was achieved. Flow phenotype cluster of differentiation 3+-T‑cell receptor γδ+ of the γδ T cells in the first 7‑17 days achieved a higher proportion and showed no significant differences between 10 days. Secretion of the cytokines interferon‑γ and tumor necrosis factor‑α gradually increased in the first 7‑14 days. The maximum was achieved on day 14, and subsequently began to decrease. The cytolytic activity of the γδ T cells to kill the SGC‑7901 cells in the first 7‑14 days had an improved killing effect, a slight decline from the first 17 days; in the effector cell to target cell (E:T) ratio 20:1, 10:1 and 5:1 conditions, γδ T cells kill SGC‑7901 cells more effectively than 1:1 and 1:2. In conclusion, γδ T cells cultured in the first 7‑14 days are suitable for clinical transfusion, and the optimal transfusion time is day 10. An E:T ratio >5:1 is preferred.
View Figures |
Figure 1
|
 |
Figure 2
|
 |
Figure 3
|
 |
Figure 4
|
 |
Figure 5
|
 |
Figure 6
|
 |
Figure 7
|
View References
|
1
|
Holtmeier W and Kabelitz D: Gammadelta T
cells link innate and adaptive immune responses. Chem Immunol
Allergy. 86:151–183. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carding SR and Egan PJ: Gammadelta T
cells: Functional plasticity and heterogeneity. Nat Rev Immunol.
2:336–345. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rettinger E, Meyer V, Kreyenberg H, et al:
Cytotoxic capacity of IL-15-stimulated cytokine-induced killer
cells against human acute myeloid leukemia and rhabdomyosarcoma in
humanized preclinical mouse model. Front Oncol. 2:322012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang K, Zhao Y, Gao X, et al: Generation
of CIK cells under different expansion time and their biological
properties. China Medical Herald. 10:12–14. 2013.
|
|
5
|
Beetz S, Marischen L, Kabelitz D and Wesch
D: Human gamma delta T cells: Candidates for the development of
immunotherapeutic strategies. Immunol Res. 37:97–111. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cao Y: Antitumor actions of γδT
lymphocytes. Int J Immunol. 29:357–360. 2006.
|
|
7
|
Viey E, Fromont G, Escudier B, Morel Y, Da
Rocha S, Chouaib S and Caignard A: Phosphostim-activated gamma
delta T cells kill autologous metastatic renal cell carcinoma. J
Immunol. 174:1338–1347. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Caccamo N, Meraviglia S, Scarpa F, La
Mendola C, Santini D, Bonanno CT, Misiano G, Dieli F and Salerno A:
Aminobisphosphonate-activated gammadelta T cells in immunotherapy
of cancer: Doubts no more. Expert Opin Biol Ther. 8:875–883. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kabelitz D, Wesch D and He W: Perspectives
of gammadelta T cells in tumor immunology. Cancer Res. 67:5–8.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yoshida Y, Nakajima J, Wada H and Kakimi
K: γδ T-cell immunotherapy for lung cancer. Surg Today. 41:606–611.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li D, Shuxiang Z, Zhu M, et al: Effects of
glucose and glutamine concentration on the growth and metabolism of
hybridoma cells. J East China Univ Sci Technol. 29:359–362.
2003.
|
|
12
|
Gao Y, Yang W, Pan M, Scully E, Girardi M,
Augenlicht LH, Craft J and Yin Z: Gamma delta T cells provide an
early source of interferon gamma in tumor immunity. J Exp Med.
198:433–442. 2003. View Article : Google Scholar : PubMed/NCBI
|
